Literature DB >> 15571429

Optimising exercise training in peripheral arterial disease.

Andrew C Bulmer1, Jeff S Coombes.   

Abstract

Peripheral arterial disease (PAD) is an obstructive condition where the flow of blood through peripheral arteries is impeded. During periods of increased oxygen demand (e.g. during exercise), peripheral limb ischaemia occurs, resulting in the sensation of muscle pain termed 'claudication'. As a result of claudication, subjects' ability to exercise is greatly reduced affecting their quality of life. Although many treatment options for patients with PAD exist, exercise training is an effective and low-cost means of improving functional ability and quality of life. Currently, there are limited specific recommendations to assist the exercise prescription and programming of these individuals. This review summarises data from 28 exercise training studies conducted in patients with PAD and formulates recommendations based on their results. Exercise training for patients with PAD should involve three training sessions per week comprising 45 minutes of intermittent treadmill walking in a supervised environment for a time period of 20 weeks or more. Encouragement and direction is given to further research aimed at investigating the effectiveness of training programmes in these patients.

Entities:  

Mesh:

Year:  2004        PMID: 15571429     DOI: 10.2165/00007256-200434140-00004

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  50 in total

Review 1.  Epidemiological research on peripheral vascular disease.

Authors:  F G Fowkes
Journal:  J Clin Epidemiol       Date:  2001-09       Impact factor: 6.437

Review 2.  Peripheral arterial disease of the lower extremity.

Authors:  C D Lewis
Journal:  J Cardiovasc Nurs       Date:  2001-07       Impact factor: 2.083

3.  Metabolic activity of skeletal muscle in patients with peripheral arterial insufficiency.

Authors:  A G Dahllöf; P Björntorp; J Holm; T Scherstén
Journal:  Eur J Clin Invest       Date:  1974-02       Impact factor: 4.686

4.  Value of a supervised exercise program for the therapy of arterial claudication.

Authors:  R B Patterson; B Pinto; B Marcus; A Colucci; T Braun; M Roberts
Journal:  J Vasc Surg       Date:  1997-02       Impact factor: 4.268

5.  Peripheral arterial disease detection, awareness, and treatment in primary care.

Authors:  A T Hirsch; M H Criqui; D Treat-Jacobson; J G Regensteiner; M A Creager; J W Olin; S H Krook; D B Hunninghake; A J Comerota; M E Walsh; M M McDermott; W R Hiatt
Journal:  JAMA       Date:  2001-09-19       Impact factor: 56.272

6.  Increasing exercise tolerance of persons limited by claudication pain using polestriding.

Authors:  W Edwin Langbein; Eileen G Collins; Cynthia Orebaugh; Christine Maloney; Karla J Williams; Fred N Littooy; Lonnie C Edwards
Journal:  J Vasc Surg       Date:  2002-05       Impact factor: 4.268

7.  Prevalence of peripheral arterial disease: persistence of excess risk in former smokers.

Authors:  Bess Fowler; Konrad Jamrozik; Paul Norman; Yvonne Allen
Journal:  Aust N Z J Public Health       Date:  2002       Impact factor: 2.939

8.  Exercise training improves functional status in patients with peripheral arterial disease.

Authors:  J G Regensteiner; J F Steiner; W R Hiatt
Journal:  J Vasc Surg       Date:  1996-01       Impact factor: 4.268

9.  Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis.

Authors:  A W Gardner; E T Poehlman
Journal:  JAMA       Date:  1995-09-27       Impact factor: 56.272

10.  Pain due to tissue acidosis: a mechanism for inflammatory and ischemic myalgia?

Authors:  U Issberner; P W Reeh; K H Steen
Journal:  Neurosci Lett       Date:  1996-04-26       Impact factor: 3.046

View more
  8 in total

1.  Supervised walking exercise therapy improves gait biomechanics in patients with peripheral artery disease.

Authors:  Molly N Schieber; Iraklis I Pipinos; Jason M Johanning; George P Casale; Mark A Williams; Holly K DeSpiegelaere; Benjamin Senderling; Sara A Myers
Journal:  J Vasc Surg       Date:  2019-08-20       Impact factor: 4.268

2.  Dietary nitrate reduces muscle metabolic perturbation and improves exercise tolerance in hypoxia.

Authors:  Anni Vanhatalo; Jonathan Fulford; Stephen J Bailey; James R Blackwell; Paul G Winyard; Andrew M Jones
Journal:  J Physiol       Date:  2011-09-12       Impact factor: 5.182

Review 3.  Exercise training and peripheral arterial disease.

Authors:  Tara L Haas; Pamela G Lloyd; Hsiao-Tung Yang; Ronald L Terjung
Journal:  Compr Physiol       Date:  2012-10       Impact factor: 9.090

Review 4.  Management of lower extremity peripheral arterial disease.

Authors:  Andrew W Gardner; Azhar Afaq
Journal:  J Cardiopulm Rehabil Prev       Date:  2008 Nov-Dec       Impact factor: 2.081

Review 5.  Intermittent Claudication in Physiotherapists' Practice.

Authors:  Anna Spannbauer; Maciej Chwała; Tomasz Ridan; Arkadiusz Berwecki; Piotr Mika; Anita Kulik; Małgorzata Berwecka; Maria T Szewczyk
Journal:  Biomed Res Int       Date:  2019-09-18       Impact factor: 3.411

Review 6.  Exercise training for intermittent claudication: a narrative review and summary of guidelines for practitioners.

Authors:  Amy E Harwood; Sean Pymer; Lee Ingle; Patrick Doherty; Ian C Chetter; Belinda Parmenter; Christopher D Askew; Gary A Tew
Journal:  BMJ Open Sport Exerc Med       Date:  2020-11-05

7.  Effects of exercise prescribed at different levels of claudication pain on walking performance in patients with intermittent claudication: a protocol for a randomised controlled trial.

Authors:  Stefan T Birkett; Jonathan Sinclair; Sally A Seed; Sean Pymer; Edward Caldow; Lee Ingle; Amy E Harwood; Anselm Egun
Journal:  Ther Adv Cardiovasc Dis       Date:  2022 Jan-Dec

8.  How Well Do Randomized Controlled Trials Reflect Standard Care: A Comparison between Scientific Research Data and Standard Care Data in Patients with Intermittent Claudication undergoing Supervised Exercise Therapy.

Authors:  S Dörenkamp; E P E Mesters; M W G Nijhuis-van der Sanden; J A W Teijink; R A de Bie; T J Hoogeboom
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.